Ignite Creation Date:
2025-12-24 @ 3:21 PM
Ignite Modification Date:
2026-02-01 @ 9:48 AM
Study NCT ID:
NCT03604692
Status:
COMPLETED
Last Update Posted:
2025-09-15
First Post:
2018-07-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 1/2 Study to Evaluate Axatilimab in Participants With Active cGVHD
Sponsor:
Syndax Pharmaceuticals
Organization: